Table 1.
Characteristics of included studies.
| Study | Country | Language | Recruitment time frame | Sample | Age, yearsa | Sex |
Immunosuppression | Immunodeficiency/HIV | |
|---|---|---|---|---|---|---|---|---|---|
| Male | Female | ||||||||
| Fang XW3 | China | Chinese | 2020.1.22-2020.2.18 | 79 | 45.1(16.6) | 45 | 34 | 1(1.27%) | |
| Feng Y4 | China | English | 2020.1.1-2020.2.15 | 476 | 53(40-64) | 271 | 205 | 7(1.47%) | |
| Zhang GQ5 | China | English | 2020.1.2-2020.2.10 | 221 | 55(39-66.5) | 108 | 113 | 3(1.36%) | |
| Guan WJ6 | China | English | 2019.12.11-2020.1.31 | 1590 | 48.9(16.3) | 904 | 686 | 3(0.19%) | |
| Wang DW7 | China | English | 2020.1.1-2020.1.28 | 138 | 56 (42-68) | 75 | 63 | 2(1.45%) | |
| Wu J8 | China | English | 2020.1.20-2020.2.19 | 280 | 43.1(19.0) | 151 | 129 | 1(0.36%) | |
| Yuan J9 | China | Chinese | 2020.1.24-2020.2.23 | 223 | 46.5(16.1) | 106 | 117 | 1(0.45%) | |
| Argenziano MG10 | USA | English | 2020.3.1-2020.4.15 | 1000 | 61.7(17.5) | 596 | 404 | 21(2.10%) | |
a
Age data presented as median (IQR) or mean (SD). HIV: human immunodeficiency virus.